1009 — Orlando, Florida

1009 is a clinical research site located in Orlando, Florida, United States 32803.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

1009 has participated in 1 clinical trials.

Therapeutic areas: Paroxysmal Supraventricular Tachycardia.

Sponsors: Milestone Pharmaceuticals Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Orlando

Browse all research sites in Florida · View every site in Orlando

• Investigational Drug Services, Florida Hospital
• Florida Hospital Cardiovascular Research Institute
• FAAST Center at the University of Central Florida
• Florida Hospital Center for Hemostasis & Thrombosis (Laboratory)
• Florida Hospital Cancer Institute SC
• University of Florida
• Florida Hospital Sports Medicine & Rehabilitation - RDV
• Nemours Children's Hospital/Endocrinology
• Nemours Children's Hospital - Florida - Hematology / Oncology
• Florida Hospital Center for Interventional Endoscopy
• Nemours Children's Hospital /ID# 234429
• Nemours Childrens Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 1009?

1009 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 1009 conducted?

1009 has 1 clinical trials on record. Their work covers Paroxysmal Supraventricular Tachycardia.

Is 1009 accredited by Crixeo Clinical Trials?

1009 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 1009?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.